PTC Therapeutics` NDA for Sepiapterin Accepted for Phenylketonuria
01 Oct 2024 //
PR NEWSWIRE
PTC Therapeutics Reports Q2 2024 Results And Corporate Update
08 Aug 2024 //
PR NEWSWIRE
PTC Therapeutics Announces Validation of Sepiapterin European MAA
28 May 2024 //
PR NEWSWIRE
PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA
28 Mar 2024 //
PR NEWSWIRE
PTC Therapeutics Announces Presentation on PKU and Sepiapterin
11 Jul 2023 //
PR NEWSWIRE
PTC Therapeutics Successfully Completes Acquisition of Censa Pharmaceuticals
01 Jun 2020 //
PRNEWSWIRE
PTC Therapeutics to Acquire Censa Pharmaceuticals
06 May 2020 //
PRNEWSWIRE